Skip to main content
. 2017 Mar 1;8:86. doi: 10.3389/fphys.2017.00086

Figure 8.

Figure 8

Schematic model of Dex-modulated signaling. Dex, dexmedetomidine; α2A-AR, α2A-adrenoceptor; NKCC1, Na+-K+-2Cl cotransporter1; AE2, anion exchanger2; SLC26A6, solute carrier 26 family A6; Nox4, NADPH oxidase 4; LPS, lipopolysaccharide; TLR4, toll-like receptor 4; PDE, phosphodiesterase; YOH, yohimbine. Acute (black) and long-lasting (red) treatment with Dex.